Nov 25, 2021
A double-blind, randomized, placebo-controlled trial conducted
to assess the role of chlorthalidone for hypertension in advanced
chronic kidney disease.
Season-3 is here! Tune in for InpharmD's podcast series, as we bring you clinical summaries and critiques of the most trending medical literature on the market.
Having trouble logging in?